No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
362 |
4. Check minimum number of eventsNone |
362 |
5. Include endpointsNone |
362 |
6. Filter based on genotype QC (FinnGen only) |
362 |
Control definitions (FinnGen only)
- Control exclude
- AB1_HIV
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF5
Similar endpoints
↥List of similar endpoints to
Unspecified human immunodeficiency virus [HIV] disease
based on the number of shared cases.
Similar with more cases:
- Human immunodeficiency virus [HIV] disease
- Certain infectious and parasitic diseases
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 2230 | 539 | 1557 |
| Only index persons | 1747 | 492 | 1255 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.04 | 0.02 | 0.04 |
| Only index persons | 0.04 | 0.02 | 0.05 |
| Median age at first event (years) | |||
| Whole population | 39.14 | 34.60 | 41.16 |
| Only index persons | 39.53 | 34.14 | 41.64 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 362 | 73 | 289 |
| Unadjusted period prevalence (%) | 0.11 | 0.02 | 0.13 |
| Median age at first event (years) | 41.35 | 40.13 | 41.66 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 323
- Matched controls
- 3230
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
B24
ICD-10 Finland
Unspecified human immunodeficiency virus [HIV] disease
+∞
323.0
318
*
B23.1
ICD-10 Finland
HIV disease resulting in (persistent) generalized lymphadenopathy
+∞
323.0
275
*
WW200
NOMESCO Finland
Immunization
508.0
295.5
258
25
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
47.4
158.5
201
108
Z21
ICD-10 Finland
Asymptomatic human immunodeficiency virus [HIV] infection status
+∞
130.2
116
*
B23.8
ICD-10 Finland
HIV disease resulting in other specified conditions
+∞
103.9
94
*
Z25.1
ICD-10 Finland
Need for immunization against influenza
28.4
70.0
97
48
GD1AA
NOMESCO Finland
Thorax X-ray examination
4.4
34.8
193
810
Z11.3
ICD-10 Finland
Special screening examination for infections with a predominantly sexual mode of transmission
7.4
33.8
88
155
B23.0
ICD-10 Finland
Acute HIV infection syndrome
+∞
32.9
31
*
A56.3
ICD-10 Finland
Chlamydial infection of anus and rectum
176.9
31.3
32
*
A51.0
ICD-10 Finland
Primary genital syphilis
306.6
28.2
28
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
7.0
26.6
70
122
E78.5
ICD-10 Finland
Hyperlipidaemia, unspecified
8.1
24.7
58
85
B18.2
ICD-10 Finland
Chronic viral hepatitis C
18.8
24.2
37
22
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
7.0
21.7
56
94
A54.6
ICD-10 Finland
Gonococcal infection of anus and rectum
+∞
20.0
19
*
A54.0
ICD-10 Finland
Gonococcal infection of lower genitourinary tract without periurethral or accessory gland abscess
212.4
19.8
20
*
A51.9
ICD-10 Finland
Early syphilis, unspecified
+∞
18.9
18
*
A54.5
ICD-10 Finland
Gonococcal pharyngitis
189.9
17.7
18
*
A63.0
ICD-10 Finland
Anogenital (venereal) warts
7.2
17.5
43
67
K05.19
ICD-10 Finland
Gingivitis (chronic) ulcerative
13.1
17.2
30
25
B20.6
ICD-10 Finland
HIV disease resulting in Pneumocystis jirovecii pneumonia
+∞
16.8
16
*
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
3.3
16.4
96
365
Z01.2
ICD-10 Finland
Dental examination
2.7
15.9
159
852
QAJ99
NOMESCO Finland
Other aesthetic operations on skin of head or neck
+∞
15.7
15
*
A53.9
ICD-10 Finland
Syphilis, unspecified
+∞
15.7
15
*
J05AB01
ATC
aciclovir; systemic
3.4
15.3
86
313
K02.9
ICD-10 Finland
Dental caries, unspecified
12.7
14.9
26
22
N05CF01
ATC
zopiclone; oral
2.8
14.4
114
525
O98.5
ICD-10 Finland
Other viral diseases complicating pregnancy, childbirth and the puerperium
+∞
13.6
13
*
B18.1
ICD-10 Finland
Chronic viral hepatitis B without delta-agent
145.8
13.6
14
*
C10AA07
ATC
rosuvastatin; oral
3.0
13.5
88
353
A51.3
ICD-10 Finland
Secondary syphilis of skin and mucous membranes
135.0
12.5
13
*
R50.9
ICD-10 Finland
Fever, unspecified
3.4
12.4
64
218
ULA02
NOMESCO Finland
Kolposcopy
5.4
12.3
37
75
J18.9
ICD-10 Finland
Pneumonia, unspecified
3.0
12.0
77
304
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
4.6
11.9
42
102
K03.65
ICD-10 Finland
Deposits [accretions] on teeth betel
2.8
11.9
86
368
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.3
11.5
62
216
B02.9
ICD-10 Finland
Zoster without complication
7.1
11.2
27
41
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.6
10.9
93
437
F43.29
ICD-10 Finland
Adaptation disorder UNS
7.4
10.8
25
36
K02.2
ICD-10 Finland
Caries of cementum
7.0
10.7
26
40
R87.6
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal cytological findings
4.9
10.6
34
75
WYA30
SPAT
NA
113.5
10.5
11
*
R74
ICPC
Upper respiratory infection acute
2.4
10.5
107
551
B20.9
ICD-10 Finland
HIV disease resulting in unspecified infectious or parasitic disease
+∞
10.5
10
*
B90
ICPC
HIV-infection/AIDS
+∞
10.5
10
*
R4110
NOMESCO Finland
Physiotherapy
2.5
10.4
96
468
F15.2
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome
19.6
10.4
15
8
F11.22
ICD-10 Finland
Addiction-induced dependence is currently independent but uses substitute intermittent medication
24.3
10.3
14
6
A56.0
ICD-10 Finland
Chlamydial infection of lower genitourinary tract
9.6
10.2
20
22
TAB00
NOMESCO Finland
Lumbar puncture
5.4
10.2
30
60
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
5.0
9.8
31
67
K05.31
ICD-10 Finland
Periodontitis pronounced
3.6
9.8
45
139
LDA20
NOMESCO Finland
Biopsy of vaginal cervix
5.3
9.7
29
59
N06AB04
ATC
citalopram; systemic
2.6
9.7
77
345
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
6.6
9.6
24
39
O99.1
ICD-10 Finland
Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium
102.9
9.5
10
*
N05BA04
ATC
oxazepam; oral
2.5
8.9
81
387
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
5.4
8.7
25
49
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
2.8
8.6
56
222
N05CD07
ATC
temazepam; oral
3.1
8.3
47
169
F15.1
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, harmful use
34.3
8.1
10
*
F15.5
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, psychotic disorder
22.7
8.1
11
5
J01MA12
ATC
levofloxacin; systemic
2.5
7.9
64
286
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
25.7
7.6
10
*
0788B
ICD-9 Finland
Other diseases due to viruses and Chlamydiae, Other specified diseases due to viruses and Chlamydiae[HIV-INFEKTIO,OIREISET TAUDINKUVAT]
+∞
7.3
7
*
B21.3
ICD-10 Finland
HIV disease resulting in other malignant neoplasms of lymphoid, haematopoietic and related tissue
+∞
7.3
7
*
B20.1
ICD-10 Finland
HIV disease resulting in other bacterial infections
+∞
7.3
7
*
B20.4
ICD-10 Finland
HIV disease resulting in candidiasis
+∞
7.3
7
*
B20.0
ICD-10 Finland
HIV disease resulting in mycobacterial infection
+∞
7.3
7
*
S02.51
ICD-10 Finland
Fracture of tooth, open
2.9
7.3
43
160
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.6
7.3
55
237
XF400
NOMESCO Finland
ECG with 12 standard connections
2.6
7.2
54
230
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.3
7.2
69
338
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
3.3
7.1
34
110
N06AX11
ATC
mirtazapine; oral
2.0
7.0
106
630
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
2.5
6.8
55
246
F11.29
ICD-10 Finland
Addiction caused by opiates UNS
40.9
6.8
8
*
JX1XE
NOMESCO Finland
Other ultrasound examinaton of alimentary organs
23.1
6.7
9
*
D07AA02
ATC
hydrocortisone; topical
2.6
6.6
51
221
A01AB04
ATC
amphotericin B; local oral
5.5
6.6
18
34
TQW99
NOMESCO Finland
Other minor procedure on skin
4.9
6.5
20
43
J05AB11
ATC
valaciclovir; oral
2.7
6.5
44
176
N05BA01
ATC
diazepam; systemic, rectal
2.5
6.5
50
217
B17.1
ICD-10 Finland
Acute hepatitis C
71.2
6.4
7
*
SDE04
NOMESCO Finland
Periodontal treatment by dental hygienist, very extensive
2.6
6.3
47
202
A52.1
ICD-10 Finland
Symptomatic neurosyphilis
+∞
6.3
6
*
B59
ICD-10 Finland
Pneumocystosis
+∞
6.3
6
*
B23
ICD-10 Finland
Human immunodeficiency virus [HIV] disease resulting in other conditions
+∞
6.3
6
*
A51.5
ICD-10 Finland
Early syphilis, latent
+∞
6.3
6
*
A55
ICD-10 Finland
Chlamydial lymphogranuloma (venereum)
+∞
6.3
6
*
0788C
ICD-9 Finland
Other diseases due to viruses and Chlamydiae, Other specified diseases due to viruses and Chlamydiae[AIDS, IMMUUNIKATO]
+∞
6.3
6
*
F19.25
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances continuously used
27.2
6.3
8
*
D11
ICPC
Diarrhoea
2.6
6.3
44
183
-1
NOMESCO Finland
NA
1.9
6.3
117
746
C10AA01
ATC
simvastatin; oral
0.4
6.2
26
592
F19.29
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances UNS
8.8
6.1
12
14
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
1.9
6.1
120
778
Z03
ICD-10 Finland
Medical observation and evaluation for suspected diseases and conditions, ruled out
3.3
6.0
28
89
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3017143) Hepatitis C virus Ab [Presence] in Serum
333
406
90.90
308.99
5.5
1.6
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
280
250
46.03
307.67
4.8
1.4
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
352
12
10583.47
307.65
16.1
1.3
u/ml
361.4
—
—
222
0
(3037121) Protein [Mass/volume] in Urine
324
84
358.92
307.65
7.5
4.0
g/l
0.1
0.3
1.61
313
39
(3003458) Phosphate [Moles/volume] in Serum or Plasma
345
366
180.43
307.65
14.6
7.0
mmol/l
0.9
1.0
8.26
345
349
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
260
23
398.64
307.65
2.9
2.0
e6/l
742.5
589.3
0.63
37
12
(42870588) Differential panel, method unspecified - Blood
340
959
42.88
148.68
14.5
5.9
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
257
578
12.88
131.34
3.7
2.9
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
177
254
12.68
130.39
3.1
1.8
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
70
11
78.65
129.33
3.5
1.5
—
—
—
0
0
(40758558) Short blood count panel - Blood
274
681
13.44
127.61
14.4
6.6
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
300
867
15.36
120.61
5.1
3.4
e6/l
35.3
118.2
0.83
153
623
(3011412) CD3 cells [#/volume] in Blood
80
30
33.95
120.12
5.4
2.2
e9/l
1.5
0.9
3.31
44
14
(3022096) Basophils/100 leukocytes in Blood
351
1326
55.20
107.60
19.3
6.2
%
0.8
0.7
2.85
351
1256
(3006504) Eosinophils/100 leukocytes in Blood
352
1363
58.29
104.39
19.3
6.2
%
2.9
2.9
0.36
352
1289
(3019069) Monocytes/100 leukocytes in Blood
352
1371
57.74
103.51
19.4
6.4
%
9.0
8.7
2.14
352
1307
(3018010) Neutrophils/100 leukocytes in Blood
352
1390
56.47
101.45
19.0
6.0
%
50.3
57.4
35.06
352
1327
(3002030) Lymphocytes/100 leukocytes in Blood
352
1414
54.92
98.91
19.4
6.1
%
36.1
27.8
47.89
352
1347
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
256
771
8.92
92.04
1.9
1.7
mmol/l
1.5
1.6
1.07
251
660
(3037467) Urinalysis macro (dipstick) panel - Urine
354
1836
42.93
84.42
8.7
3.5
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
65
37
21.19
82.02
1.1
1.1
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
53
19
32.51
79.86
5.4
2.4
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
318
1337
12.34
77.18
4.2
2.8
estimate
0.0
0.0
0.00
40
220
(3021601) Nitrite [Presence] in Urine by Test strip
317
1329
12.14
77.13
7.1
3.9
estimate
0.0
0.0
0.00
40
247
(3035350) Ketones [Presence] in Urine by Test strip
317
1332
12.10
76.85
4.3
2.8
estimate
0.0
0.0
0.00
40
239
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
92
109
10.98
75.19
5.0
1.9
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
72
62
14.25
72.75
1.2
1.1
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
43
12
40.53
69.47
5.7
1.8
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
357
2152
48.68
67.19
13.9
8.0
u/l
77.5
77.8
0.05
357
2044
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
92
135
8.80
62.96
5.2
1.9
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
71
75
11.53
62.51
1.2
1.1
—
—
—
0
0
(3013762) Body weight Measured
57
0
+∞
61.21
1.1
0.0
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
42
23
20.53
53.34
2.5
1.6
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
192
685
4.84
49.27
3.4
2.7
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
191
695
4.70
47.38
3.4
2.8
e6/l
0.3
0.3
0.20
144
513
(3002582) Erythrocytes [#/volume] in Urine
197
759
4.50
44.69
3.4
2.9
e6/l
14.2
48.5
2.12
151
577
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
50
9
64.15
43.69
3.2
1.4
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
56
72
9.02
42.04
2.4
3.7
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
62
92
7.93
41.28
1.2
1.3
miu/ml
171.0
244.4
0.56
22
45
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
207
901
4.03
37.97
3.7
3.0
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
42
9
52.57
35.56
4.8
1.4
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
117
354
4.41
35.55
3.8
1.7
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
125
399
4.26
35.31
4.2
1.8
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
119
398
3.96
31.03
2.8
2.7
e6/l
2.5
1.1
0.50
59
203
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
31
29
11.60
29.05
2.1
1.7
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
121
429
3.73
28.70
2.9
2.6
e6/l
0.9
0.9
0.06
61
233
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
355
2885
12.92
23.80
8.7
4.0
mmol/l
6.0
6.0
0.03
355
2699
(3003327) Ova and parasites identified in Stool by Light microscopy
44
84
5.82
22.63
2.4
1.6
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
122
496
3.20
22.57
2.9
2.4
e6/l
3.2
5.3
0.63
117
439
(3026782) Osmolality of Urine
118
479
3.17
21.79
3.0
2.4
mosm/kgh2o
617.7
597.0
0.47
111
417
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
29
37
8.43
21.58
2.1
2.6
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
118
483
3.14
21.44
1.5
1.7
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
27
35
8.26
19.81
1.1
1.3
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
46
104
4.92
19.55
1.5
1.6
g/l
1.2
1.6
1.80
41
95
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
357
3081
12.49
17.18
8.9
4.1
mmol/l
1.3
1.3
2.86
357
2907
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
347
2757
7.24
16.92
8.6
5.1
mmol/mol
35.9
39.6
14.90
347
2630
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
65
214
3.48
16.54
2.3
2.3
ml/min/173m2
78.2
70.6
1.00
37
91
(3002385) Erythrocyte distribution width [Ratio]
331
2559
4.43
16.25
28.8
15.0
%
13.3
13.5
2.24
331
2514
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
356
3084
10.31
15.97
9.0
4.2
mmol/l
4.5
4.7
4.45
356
2922
(3009508) Creatinine [Moles/volume] in Urine
158
857
2.50
15.80
5.0
3.5
mmol/l
8.8
9.1
0.30
150
734
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
357
3111
11.68
15.77
9.1
4.4
mmol/l
2.8
2.9
0.68
357
2939
(3030905) Polymorphonuclear cells [#/volume] in Blood
28
49
6.11
15.64
4.0
3.5
e9/l
2.9
4.3
3.73
28
49
(3016244) Insulin [Units/volume] in Serum or Plasma
18
19
9.92
15.34
6.6
3.1
mu/l
43.6
33.6
0.46
18
19
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
28
51
5.87
15.02
4.0
3.9
%
49.1
54.9
1.73
28
51
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
27
49
5.87
14.53
1.2
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
27
49
5.87
14.53
1.2
1.4
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
106
496
2.61
14.25
1.4
1.4
nmol/l
17.3
20.1
1.85
100
431
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
37
92
4.37
13.91
1.2
1.7
iu/ml
0.0
0.1
0.68
19
17
(1761868) Lipid panel - Serum or Plasma
69
1432
0.36
13.58
4.4
2.5
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
13
10
13.45
13.43
1.5
1.4
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
17
20
8.87
13.35
1.1
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
17
20
8.87
13.35
1.1
1.0
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
346
2858
5.77
13.33
22.7
11.1
ml/min/173m2
88.0
88.7
0.25
333
2356
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
40
114
3.82
12.51
1.4
1.4
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
17
22
8.06
12.38
1.1
1.0
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
72
300
2.75
12.02
3.5
4.1
u/l
221.1
248.5
0.78
72
286
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
19
30
6.63
11.66
5.2
3.4
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
34
91
4.02
11.59
1.1
1.2
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
348
2988
5.26
10.42
16.4
12.6
mg/l
21.1
23.1
0.58
280
2344
(3001964) Herpes simplex virus Ag [Presence] in Specimen
13
6
22.40
9.41
1.2
2.5
—
—
—
0
0
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
13
7
19.20
8.99
1.6
1.0
iu/ml
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
30
90
3.54
8.69
2.9
3.1
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
13
8
16.78
8.61
1.2
1.0
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
52
218
2.62
8.47
4.8
4.4
%
0.4
0.4
—
8
57
(3021440) Promyelocytes/100 leukocytes in Blood
52
222
2.57
8.15
5.1
4.9
%
0.0
0.2
—
9
71
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
44
176
2.71
7.85
1.5
1.5
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
49
207
2.58
7.84
5.3
5.0
%
0.0
0.0
—
8
63
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
58
267
2.40
7.74
1.7
1.7
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
53
237
2.45
7.53
5.1
4.7
%
0.4
0.9
—
9
78
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
94
532
2.04
7.52
2.2
2.0
mg/l
2.6
3.1
1.20
83
464
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
23
67
3.60
6.96
1.2
1.2
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
57
277
2.26
6.69
1.8
1.8
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
33
125
2.80
6.52
6.6
4.0
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
12
454
0.24
6.52
1.2
1.8
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
117
748
1.83
6.38
3.1
3.5
mg/l
75.1
235.5
0.71
88
512
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
46
208
2.39
6.37
1.8
1.4
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
7
308
0.21
6.22
1.1
1.4
—
—
—
0
0
(3018418) pH of Serum or Plasma
112
719
1.81
5.97
3.2
4.3
ph
7.4
7.4
0.06
13
140
(40761511) CBC panel - Blood by Automated count
289
3210
0.51
5.86
12.3
11.3
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
17
498
0.31
5.83
1.4
1.4
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
23
76
3.16
5.75
1.2
1.7
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
25
89
2.94
5.53
3.6
3.5
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
31
127
2.58
5.28
1.5
1.6
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
107
705
1.73
5.11
5.2
4.7
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
33
143
2.44
5.02
1.8
1.2
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
10
20
5.11
4.80
1.8
3.0
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
151
1108
1.62
4.72
6.3
7.1
mmol/l
1.2
1.2
0.21
144
1033
(3023520) Reticulocytes [#/volume] in Blood
38
181
2.23
4.68
1.8
2.9
e9/l
64.8
76.5
1.07
21
136
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
131
933
1.63
4.59
1.9
1.8
pmol/l
98.8
95.3
0.46
80
517
(3003338) MCHC [Mass/volume]
311
2761
1.90
4.38
30.0
14.9
g/l
336.9
335.6
1.85
311
2750
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
65
386
1.83
4.36
1.8
1.9
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
329
2979
2.15
4.35
28.4
12.5
%
42.1
42.1
0.00
292
2449
(3005719) IgG [Mass/volume] in Serum or Plasma
44
232
2.02
4.19
1.5
2.2
g/l
12.9
10.7
1.71
38
210
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
58
337
1.86
4.16
2.3
3.0
umol/l
8.8
8.5
0.05
50
296
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
16
52
3.17
4.13
2.3
1.7
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
21
81
2.69
4.05
1.1
1.6
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
46
250
1.96
4.03
3.0
3.7
mmol/l
0.2
2.0
1.43
34
203
(42529406) Shigella sp [Presence] in Stool by Culture
21
82
2.66
3.96
1.4
1.1
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
32
154
2.18
3.86
2.1
5.4
ng/l
74.6
95.6
1.02
32
148
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
6
5
12.17
3.77
3.5
1.6
—
—
—
0
0
(3012544) pH of Venous blood
46
256
1.91
3.77
3.0
3.8
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
110
790
1.56
3.58
3.6
4.2
mg/mmol
11.5
9.9
0.18
77
535
(3006653) Thiamine [Moles/volume] in Blood
8
13
6.26
3.52
1.0
1.0
nmol/l
160.9
174.5
—
8
13
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
14
47
3.06
3.45
2.3
1.6
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
61
382
1.72
3.41
1.2
1.3
titre
280.0
373.1
—
10
67
(3000494) Fungus identified in Specimen by Culture
58
359
1.73
3.38
1.3
1.4
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
155
1216
1.48
3.28
6.6
7.8
mmol/l
1.2
1.2
0.04
136
1043
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
16
60
2.74
3.27
1.0
1.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
31
158
2.05
3.26
1.3
1.2
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
7
11
6.46
3.20
1.0
1.0
umol/l
31.1
27.8
—
7
11
(1001926) Buprenorphine [Presence] in Urine by Screen method
29
146
2.07
3.15
3.6
2.7
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
9
20
4.59
3.13
1.0
1.3
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
130
992
1.48
3.12
2.1
2.3
nmol/l
72.6
71.5
0.15
124
912
(3016879) Cocaine [Presence] in Urine
33
175
1.97
3.12
3.9
3.0
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
19
81
2.42
3.04
1.2
1.1
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
57
363
1.68
3.00
1.1
1.3
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
57
363
1.68
3.00
2.1
1.7
nmol/l
952.7
1182.6
1.39
51
295
(3036489) Thrombin time
24
115
2.16
2.96
1.8
2.5
s
23.0
22.0
0.40
24
103
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
13
312
0.39
2.91
5.5
6.8
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
6
9
6.76
2.88
1.2
1.0
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
6
9
6.76
2.88
1.2
1.0
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
28
145
2.01
2.84
1.8
1.9
—
—
—
0
0
(3013512) EKG study
46
714
0.59
2.82
2.8
3.3
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
9
23
3.99
2.79
1.7
3.1
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
44
266
1.74
2.79
2.9
3.2
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
27
141
1.99
2.68
1.3
1.7
mg/l
2.1
4.5
1.50
27
101
(3023410) Appearance of Cerebral spinal fluid
10
32
3.19
2.66
3.0
1.7
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
15
61
2.52
2.65
2.4
1.5
—
—
—
0
0
(1616796) Gas panel - Central venous blood
15
61
2.52
2.65
2.6
3.6
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
33
186
1.85
2.63
3.9
2.9
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
71
496
1.54
2.55
3.1
3.4
ng/l
29.9
560.7
1.92
52
362
(3027944) Amphetamines [Presence] in Urine
33
188
1.83
2.55
3.9
2.6
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
33
189
1.82
2.51
3.9
2.8
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
33
189
1.82
2.51
4.0
2.7
—
—
—
0
0
(3012501) Base excess in Blood by calculation
15
63
2.44
2.49
2.9
3.6
mmol/l
1.3
2.7
—
6
42
(3013290) Carbon dioxide [Partial pressure] in Blood
15
63
2.44
2.49
2.9
3.7
kpa
4.7
5.1
1.54
15
63
(3027315) Oxygen [Partial pressure] in Blood
15
63
2.44
2.49
2.9
3.7
kpa
9.6
9.0
0.82
15
63
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
18
83
2.23
2.45
1.2
1.1
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
33
191
1.80
2.43
1.5
1.4
g/l
1.7
1.3
0.27
28
179
(3024891) Influenza virus A+B Ag [Presence] in Specimen
21
104
2.08
2.41
1.1
1.2
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
95
1224
0.70
2.37
2.7
3.3
%
25.5
21.3
0.92
34
443
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
209
2366
0.72
2.34
4.7
3.2
u/l
67.6
53.7
1.09
196
2254
(3026008) Bacteria identified in Urine by Culture
67
473
1.51
2.30
2.9
2.3
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
8
23
3.53
2.28
2.9
5.4
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
80
1055
0.69
2.25
2.7
3.1
ng/l
23.0
40.5
1.00
42
662
(3047352) Trisomy 18 risk [Likelihood] in Fetus
11
42
2.67
2.20
1.5
1.5
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
11
42
2.67
2.20
1.4
1.5
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
24
131
1.89
2.14
1.1
1.5
—
11.8
—
0
7
(3037756) Immunofixation for Serum or Plasma
10
37
2.75
2.12
1.3
1.5
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
10
37
2.75
2.12
1.3
1.4
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
11
43
2.61
2.11
1.5
1.6
—
—
—
0
0
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
8
25
3.25
2.10
1.1
1.1
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
77
569
1.45
2.10
1.4
1.3
g/l
3.5
2.6
1.26
36
392
(3039443) Prostate specific Ag panel - Serum or Plasma
6
160
0.36
2.07
2.0
1.6
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
15
69
2.22
2.07
1.5
2.1
mg/l
70.7
131.3
0.28
15
53
(3000991) Gas panel - Venous blood
39
249
1.63
2.06
13.7
10.9
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
18
90
2.05
2.04
1.6
1.7
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
9
32
2.86
2.01
1.1
1.5
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
9
32
2.86
2.01
1.1
1.5
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
9
32
2.86
2.01
1.1
1.5
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
8
186
0.42
1.99
1.1
1.6
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
128
1537
0.74
1.97
3.4
3.6
ug/l
2.2
1.8
0.29
119
1424
(3051611) Lipemic interference index of Serum or Plasma
8
27
3.01
1.94
3.0
5.3
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
82
624
1.41
1.91
1.7
1.9
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
8
28
2.90
1.87
1.0
1.1
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
78
592
1.40
1.84
2.0
2.2
%
1.7
1.5
1.16
64
529
(3010421) pH of Blood
15
73
2.10
1.83
2.9
3.6
ph
7.4
7.4
0.04
15
63
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
11
47
2.38
1.79
1.5
1.4
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
10
41
2.48
1.77
1.1
1.1
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
6
18
3.37
1.75
1.0
1.2
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
127
1049
1.32
1.75
5.8
8.1
inr
1.1
1.2
0.36
31
315
(3016018) Differential panel - Cerebral spinal fluid
8
30
2.70
1.73
3.5
1.6
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
7
24
2.95
1.73
1.1
1.0
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
7
24
2.95
1.73
3.1
2.5
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
7
24
2.95
1.73
1.1
1.0
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
14
68
2.10
1.72
1.2
2.0
—
1.2
—
0
10
(3026493) Urate [Moles/volume] in Serum or Plasma
59
785
0.70
1.70
2.2
2.5
umol/l
338.5
3697.5
1.75
53
714
(3042936) Bacteria identified in Isolate by Culture
54
390
1.45
1.67
2.0
2.2
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
14
69
2.07
1.67
1.4
2.1
mg/l
59.9
31.1
1.76
14
53
(3001122) Ferritin [Mass/volume] in Serum or Plasma
133
1112
1.31
1.67
2.6
2.7
ug/l
241.2
164.6
0.55
126
1055
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
11
49
2.28
1.65
1.4
1.5
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
11
49
2.28
1.65
1.4
1.5
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
11
49
2.28
1.65
1.5
1.5
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
11
49
2.28
1.65
1.4
1.5
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
98
786
1.34
1.64
5.1
3.6
mmol/l
2.4
2.3
0.29
83
711
(3021788) Differential panel - Synovial fluid
10
43
2.36
1.61
1.3
1.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
8
32
2.53
1.60
1.1
1.5
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
7
26
2.72
1.59
1.1
1.2
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
11
50
2.24
1.58
1.5
1.6
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
8
33
2.46
1.54
1.1
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
8
33
2.46
1.54
1.1
1.5
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
5
125
0.39
1.53
3.0
3.6
mmol/l
25.8
25.1
—
5
120
(3019060) Gas panel - Arterial blood
8
170
0.46
1.50
3.5
4.9
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
7
28
2.53
1.46
1.0
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
7
28
2.53
1.46
1.0
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
7
28
2.53
1.46
1.0
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
7
28
2.53
1.46
1.0
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
7
28
2.53
1.46
1.0
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
7
28
2.53
1.46
1.0
1.1
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
5
16
3.15
1.44
1.0
1.1
iu/ml
675.6
279.1
—
5
16
(3008898) HLA-B27 [Presence]
6
137
0.43
1.43
1.0
1.1
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
9
40
2.28
1.41
3.3
3.3
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
79
628
1.33
1.40
1.3
1.2
u/ml
2.4
1.2
—
8
199
(40761536) Microorganisms panel - Urine sediment
32
217
1.52
1.36
7.6
3.0
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
5
17
2.97
1.36
1.0
3.0
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
13
68
1.95
1.35
2.5
1.4
e6/l
31.1
7.5
—
8
51
(3044927) Protein electrophoresis panel - Urine
5
18
2.80
1.29
1.0
1.1
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
5
18
2.80
1.29
1.0
1.3
—
—
—
0
0
(4010399)
11
203
0.53
1.29
1.3
1.4
—
—
—
0
0
(4035726)
31
212
1.51
1.28
1.1
1.4
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
8
35
2.31
1.27
1.4
1.8
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
119
1014
1.26
1.23
2.0
1.9
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
22
140
1.61
1.23
1.1
1.1
—
6.2
—
0
5
(3012095) Magnesium [Moles/volume] in Serum or Plasma
61
476
1.34
1.23
3.0
3.8
mmol/l
0.8
0.8
0.11
53
458
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
6
26
2.33
1.19
1.3
1.6
—
—
—
0
0
(1002224) Polysomnography panel
12
210
0.56
1.19
1.1
1.1
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
15
87
1.76
1.17
2.5
2.5
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
8
154
0.51
1.17
2.0
1.6
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
221
2025
1.23
1.16
2.8
3.4
pmol/l
13.7
14.6
6.77
207
1881
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
15
88
1.74
1.13
1.0
1.1
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
8
40
2.02
1.12
1.0
1.1
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
13
73
1.81
1.12
2.3
3.8
u/ml
0.6
0.3
—
5
37
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
14
81
1.76
1.10
1.1
1.2
—
—
—
0
0
(4027681)
5
21
2.40
1.09
1.2
1.2
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
11
59
1.89
1.08
1.3
1.5
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
51
646
0.75
1.07
2.6
3.1
ng/l
929.4
774.6
0.23
46
521
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
79
652
1.27
1.06
1.9
1.8
mg/l
2.9
1.1
0.41
59
505
(3044640) Blood type and Crossmatch panel - Blood
97
822
1.25
1.05
2.2
2.4
—
—
—
0
0
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
5
22
2.29
1.03
1.0
1.6
mg/l
3.1
4.1
—
5
22
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
5
22
2.29
1.03
1.2
1.0
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
9
47
1.94
1.03
2.1
1.7
—
—
—
0
0
(4034850)
5
106
0.46
1.03
2.2
11.3
—
—
—
0
0
(3044889) 12 lead EKG panel
188
2050
0.83
1.02
2.6
3.4
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
23
156
1.51
1.01
1.2
1.2
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
13
76
1.74
1.00
1.1
1.2
u/ml
239.2
230.5
—
6
51
(40768795) Lymph node Pathology biopsy report
5
23
2.19
0.98
1.8
1.2
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
0
29
0.00
0.98
0.0
1.6
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
76
632
1.26
0.97
2.4
2.3
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
315
3027
1.31
0.96
17.2
14.0
mmol/l
3.9
4.0
2.40
307
2962
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
11
62
1.80
0.95
1.0
1.2
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
91
1057
0.81
0.93
5.4
2.8
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
24
334
0.70
0.92
1.7
1.5
—
—
—
0
0
(4198724)
6
28
2.16
0.92
1.2
1.9
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
5
101
0.49
0.91
2.6
1.2
—
2.6
—
0
7
(3021901) Oxygen saturation in Capillary blood
8
42
1.92
0.89
1.6
2.9
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
6
32
1.89
0.82
1.2
1.4
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
6
33
1.83
0.79
1.0
1.4
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
5
97
0.51
0.79
1.0
1.1
—
3.4
—
0
13
(3005570) Glucose [Moles/volume] in Urine
0
28
0.00
0.76
0.0
1.7
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
0
28
0.00
0.76
0.0
2.5
—
34.3
—
0
28
(3023511) Choriogonadotropin [Units/volume] in Urine
7
38
1.86
0.74
1.4
1.1
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
5
25
2.01
0.73
1.0
1.1
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
7
40
1.76
0.71
1.0
1.2
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
7
40
1.76
0.71
1.4
1.3
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
15
101
1.51
0.71
1.4
1.5
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
112
1245
0.85
0.69
3.5
3.9
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
7
42
1.68
0.68
1.0
1.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
5
27
1.86
0.68
4.8
1.8
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
7
43
1.64
0.67
1.0
1.3
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
311
3013
1.23
0.66
16.1
13.9
mmol/l
138.9
139.6
6.82
305
2949
(3007853) Bacteria identified in Skin by Aerobe culture
44
361
1.25
0.65
1.8
1.7
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
32
399
0.78
0.63
1.6
1.4
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
9
137
0.65
0.62
1.8
1.5
mu/l
261.7
265.5
—
9
129
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
5
30
1.68
0.61
1.2
1.4
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
5
30
1.68
0.61
1.0
2.2
—
—
—
0
0
(3019225) pH of Specimen
16
219
0.72
0.59
4.8
5.0
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
10
64
1.58
0.59
1.7
2.9
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
6
35
1.73
0.58
1.7
1.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
6
35
1.73
0.58
1.0
1.1
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
27
212
1.30
0.57
2.6
2.4
—
22.2
—
0
17
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
67
584
1.18
0.56
1.5
1.5
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
13
90
1.46
0.56
1.5
1.6
—
—
—
0
0
(3002256) Pathology report gross observation
38
313
1.24
0.56
1.2
1.2
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
6
38
1.59
0.54
1.2
1.1
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
232
2211
1.14
0.54
3.3
3.1
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
9
62
1.46
0.53
1.0
1.3
—
—
—
0
0
(44806118)
6
39
1.55
0.53
1.0
1.8
—
—
—
0
0
(44790049)
6
39
1.55
0.53
1.0
1.8
—
—
—
0
0
(44790048)
6
39
1.55
0.53
1.0
1.8
—
—
—
0
0
(44790047)
6
39
1.55
0.53
1.0
1.8
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
9
63
1.44
0.52
1.0
1.2
—
62.8
—
0
6
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
6
99
0.60
0.52
4.2
3.6
u/ml
29.8
138.0
—
6
82
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
22
171
1.31
0.51
1.1
1.2
iu/ml
136.2
119.3
—
5
62
(3048929) Epstein Barr virus Ab [Presence] in Serum
16
118
1.37
0.51
1.2
1.3
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
83
921
0.87
0.49
2.2
2.4
ug/l
0.7
0.7
0.10
61
481
(3000492) Spirometry study
33
396
0.82
0.48
1.3
1.4
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
10
68
1.48
0.47
1.2
1.4
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
11
77
1.44
0.46
1.0
1.2
—
13.7
—
0
7
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
11
77
1.44
0.46
1.0
1.2
—
3.4
—
0
7
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
7
51
1.38
0.44
1.4
1.2
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
0
16
0.00
0.41
0.0
1.0
—
27.0
—
0
9
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
0
16
0.00
0.41
0.0
1.0
—
213.4
—
0
10
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
16
0.00
0.41
0.0
1.2
—
7.3
—
0
16
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
0
16
0.00
0.41
0.0
1.3
—
26.8
—
0
11
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
0
16
0.00
0.41
0.0
1.0
—
647.2
—
0
9
(3024932) HLA-DR beta [Type]
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
0
16
0.00
0.41
0.0
6.1
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(3024471) HLA-A [Type]
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
40
462
0.85
0.40
1.4
1.3
iu/ml
29.8
31.5
0.03
11
146
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
46
401
1.17
0.40
2.9
3.3
mmol/l
2.4
2.4
0.06
33
353
(3023419) Bacteria identified in Sputum by Culture
5
34
1.48
0.40
1.8
2.5
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
18
0.00
0.40
0.0
1.7
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
0
18
0.00
0.40
0.0
1.2
—
1.1
—
0
6
(3004451) EKG impression Narrative
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
75
679
1.13
0.40
5.9
3.1
estimate
0.0
0.0
0.50
41
233
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
5
35
1.43
0.39
1.0
2.0
—
—
—
0
0
(3022145) Colonoscopy Study observation
28
333
0.83
0.39
1.3
1.3
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
19
0.00
0.39
0.0
2.8
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
19
0.00
0.39
0.0
1.3
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
262
2542
1.11
0.37
4.0
3.9
mu/l
1.9
1.8
0.13
251
2377
(4268621)
6
41
1.47
0.36
3.5
2.6
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
37
425
0.86
0.36
1.4
1.2
u/ml
5.6
8.1
—
7
181
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
6
43
1.40
0.35
1.2
1.1
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
6
44
1.37
0.34
1.3
1.8
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
10
74
1.36
0.32
1.1
1.9
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
7
54
1.30
0.30
1.4
1.2
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
7
55
1.28
0.30
1.3
2.2
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
7
56
1.25
0.29
1.1
1.9
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
12
95
1.27
0.26
1.2
1.3
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
27
235
1.16
0.26
1.1
1.2
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
9
76
1.19
0.25
1.4
1.6
ug/g
172.4
270.6
—
9
45
(3048689) Calprotectin [Mass/mass] in Stool
39
351
1.12
0.24
1.9
2.8
ug/g
280.0
139.6
0.77
28
301
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
5
40
1.25
0.22
1.0
1.6
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
2.4
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
11
0.00
0.21
0.0
7.9
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
11
0.00
0.21
0.0
8.1
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
10
0.00
0.21
0.0
1.0
—
18.8
—
0
10
(3036048) Francisella tularensis Ab [Titer] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
0
10
0.00
0.21
0.0
1.1
—
11.0
—
0
10
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
10
0.00
0.21
0.0
3.6
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
15
126
1.20
0.21
2.3
2.7
e6/l
0.0
0.1
2.98
15
120
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
8
105
0.76
0.21
2.1
2.1
—
—
—
0
0
(3006576) Bicarbonate [Moles/volume] in Blood
0
12
0.00
0.21
0.0
5.6
—
25.4
—
0
12
(3017569) Oxygen content in Arterial blood
0
12
0.00
0.21
0.0
7.3
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
0
13
0.00
0.21
0.0
1.8
—
69.2
—
0
13
(4133840)
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
3.0
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
14
0.00
0.20
0.0
3.8
—
80.0
—
0
14
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
6.0
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
6
52
1.16
0.19
1.0
1.1
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
7
61
1.15
0.17
1.1
1.1
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
62
1.13
0.17
1.0
1.7
—
—
—
0
0
(4306422)
7
62
1.13
0.17
1.4
1.3
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
13
149
0.87
0.14
1.2
1.5
u/l
12.3
5.6
—
8
124
(3023323) Follitropin [Units/volume] in Serum or Plasma
10
117
0.85
0.13
1.2
1.4
iu/l
13.1
19.0
—
5
95
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
13
148
0.87
0.12
20.3
13.1
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
48
456
1.06
0.11
1.6
1.7
pmol/l
450.1
54657289.5
0.80
43
408
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
11
96
1.15
0.10
1.1
2.0
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
11
97
1.14
0.09
1.3
1.4
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
32
302
1.07
0.09
14.5
10.3
mmol/l
-0.9
1.0
1.21
22
247
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
6
57
1.05
0.08
1.5
1.2
%
102.0
116.9
—
6
52
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
19
176
1.08
0.07
1.9
3.2
mmol/l
0.2
1.6
—
9
131
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
6
75
0.80
0.07
1.3
1.8
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
20
186
1.08
0.07
2.0
3.1
kpa
4.7
5.2
2.37
20
175
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
8
76
1.05
0.07
1.1
1.8
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
7
81
0.86
0.07
1.1
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
7
81
0.86
0.07
1.1
1.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
9
88
1.02
0.07
1.6
1.8
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
20
187
1.07
0.06
1.8
2.0
pmol/l
248.9
229.3
0.43
20
177
(40768443) Skin Pathology biopsy report
10
92
1.09
0.03
1.1
1.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
80
812
0.98
0.03
1.4
1.4
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
72
710
1.02
0.02
7.8
5.0
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
10
93
1.08
0.02
1.6
2.0
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
10
94
1.07
0.01
2.4
2.9
—
—
—
0
0
(3022313) Gas panel - Capillary blood
13
136
0.95
0.00
2.2
3.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
13
129
1.01
0.00
2.0
1.9
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
77
772
1.00
0.00
4.9
2.4
—
—
—
0
0
(40761535) Cells panel - Urine sediment
19
189
1.01
0.00
3.7
3.0
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
16
155
1.03
0.00
1.4
1.4
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
14
144
0.97
0.00
1.1
1.0
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
0
9
0.00
0.00
0.0
15.7
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
5
55
0.91
0.00
1.0
1.0
—
1.5
—
0
26
(3034988) Calcium [Moles/volume] in Capillary blood
0
9
0.00
0.00
0.0
1.1
—
1.2
—
0
9
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.7
—
17.1
—
0
9
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
9
0.00
0.00
0.0
1.1
—
1.3
—
0
9
(3000012) Reticulocyte production index
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
6
60
1.00
0.00
1.5
1.2
—
—
—
0
0
(3034891) Synovial lining cells/100 cells in Synovial fluid
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
6
63
0.95
0.00
1.0
1.6
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
6.7
—
0
5
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3013166) Neutrophils/100 leukocytes in Synovial fluid
0
6
0.00
0.00
0.0
1.2
—
46.7
—
0
6
(3001893) Eosinophils/100 leukocytes in Pleural fluid
0
5
0.00
0.00
0.0
1.4
—
2.2
—
0
5
(3022689) Creatine [Moles/volume] in Urine
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(46235168) Fasting glucose [Moles/volume] in Blood
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.2
—
2.2
—
0
6
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
6
0.00
0.00
0.0
3.2
—
9299.0
—
0
6
(3035880) pH of Pleural fluid
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
7
0.00
0.00
0.0
9.9
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
5
53
0.94
0.00
1.0
1.1
—
—
—
0
0
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
0
6
0.00
0.00
0.0
1.0
—
34.2
—
0
6
(3000919) Neutrophils/100 leukocytes in Pleural fluid
0
5
0.00
0.00
0.0
1.2
—
47.8
—
0
5
(3011436) Histone Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(44806071)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.6
—
10.0
—
0
5
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(4038314)
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
0
5
0.00
0.00
0.0
1.4
—
40.6
—
0
5
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
3.0
—
51.6
—
0
6
(4211845)
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint AB1_HIV_NOS and mortality.
Females
No dataMales
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| AB1_HIV_NOS | 3.161 [2.63, 3.81] | < 0.001 |
| Birth year | 0.985 [0.98, 0.99] | 0.002 |
During the follow-up period (1.1.1998 — 31.12.2019), 201 out of 1214 males with AB1_HIV_NOS died.
Mortality risk
Mortality risk for people of age
years, who have AB1_HIV_NOS.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | 0.477% |
| 5 | No data | 3.193% |
| 10 | No data | 8.646% |
| 15 | No data | 14.951% |
| 20 | No data | 24.987% |
Relationships between endpoints
↥Index endpoint: AB1_HIV_NOS – Unspecified human immunodeficiency virus [HIV] disease
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data